by Scott Farr | Sep 28, 2023 | Blog
The IND Filing Process and Categories Federal law mandates that drugs have an approved marketing application for interstate transport, but developers of new drugs must distribute their potential products nationwide in order to conduct clinical trials, and so must...
by Scott Farr | Sep 26, 2023 | Infographic
Download the...
by Scott Farr | Sep 20, 2023 | Case Studies
Challenge Syner-G was contracted by a Canadian Pharma Company to perform an emergency Investigation Audit triggered by an OOS of a time-critical Phase II supply at a CDMO site in India. Results Syner-G mobilized two of its experts (locally available in India)...
by Scott Farr | Sep 20, 2023 | Case Studies
Challenge Syner-G was contracted by a U.S. based virtual biopharmaceutical company, who develops drug candidates for neurological diseases, to oversee the Quality and Compliance aspects for the Drug Substances and Drug Products in various phases of Product...
by Scott Farr | Sep 20, 2023 | Case Studies
Challenge Syner-G was contracted by a virtual U.S. Biopharma company to perform the responsibilities of their Quality Assurance function, locally in India. Syner-G Team was vested with responsibility (Quality and Compliance) of two CDMO sites in India for the...
